Premium
Third dose of the BNT162b2 vaccine results in very high levels of neutralizing antibodies against SARS‐CoV ‐2: Results of a prospective study in 150 health professionals in Greece
Author(s) -
Terpos Evangelos,
Karalis Vangelis,
Sklirou Aimilia D.,
Apostolakou Filia,
NtanasisStathopoulos Ioannis,
Bagratuni Tina,
Iconomidou Vassiliki A.,
Malandrakis Panagiotis,
Korompoki Eleni,
Papassotiriou Ioannis,
Trougakos Ioannis P.,
Dimopoulos Meletios A.
Publication year - 2022
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.26468
Subject(s) - covid-19 , neutralizing antibody , medicine , virology , antibody , immunology , disease , infectious disease (medical specialty) , outbreak
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom